Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B L Stoddard

Showing results (51-60 of 54) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 54 results.
Science (New York, N.Y.)|June 2, 1995
Mutagenesis and Laue structures of enzyme intermediates: isocitrate dehydrogenaseJ M Bolduc, D H Dyer, W G Scott, et al.
Journal of Molecular Biology|July 13, 2000
Conformational changes and cleavage by the homing endonuclease I-PpoI: a critical role for a leucine residue in the active siteE A Galburt, M S Chadsey, M S Jurica, et al.
Blood|July 27, 2000
Hemophilic factor VIII C1- and C2-domain missense mutations and their modeling to the 1.5-angstrom human C2-domain crystal structureM L Liu, B W Shen, S Nakaya, et al.
Nature Communications|September 1, 2017
Hit-and-run programming of therapeutic cytoreagents using mRNA nanocarriersH F Moffett, M E Coon, S Radtke, et al.
Pageof 6

Showing results (51-60 of 54) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 54 results.
Science (New York, N.Y.)|June 2, 1995
Mutagenesis and Laue structures of enzyme intermediates: isocitrate dehydrogenaseJ M Bolduc, D H Dyer, W G Scott, et al.
Journal of Molecular Biology|July 13, 2000
Conformational changes and cleavage by the homing endonuclease I-PpoI: a critical role for a leucine residue in the active siteE A Galburt, M S Chadsey, M S Jurica, et al.
Blood|July 27, 2000
Hemophilic factor VIII C1- and C2-domain missense mutations and their modeling to the 1.5-angstrom human C2-domain crystal structureM L Liu, B W Shen, S Nakaya, et al.
Nature Communications|September 1, 2017
Hit-and-run programming of therapeutic cytoreagents using mRNA nanocarriersH F Moffett, M E Coon, S Radtke, et al.
Pageof 6